Mazdutide Survodutide cagrilintide 2.5mg+Samaglutide2.5mg MZ SUR10 CS5 CS10
TDS 11 Inquiries
682809-81-0
Pharmaceutical Grade
99%
shenzhen
sc
5mg/ 10 mg. 10 bottles
2027-12-30
tr
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceAHK-Cu, also known as Alanine-Histidine-Lysine-Copper, is a synthetic peptide that has garnered significant attention in recent years due to its potential applications in various fields, particularly in dermatology and regenerative medicine. Peptides are short chains of amino acids, and when combined with copper ions, they can exhibit unique biological activities.Certificates
-
TDS
Basic Info-
Product Name:
AHK-Cu
Other Name:ALA-HIS-LYS-CU;Copper Peptide 1:1;L-Alanyl-κN-L-histidyl-κN,κN3-L-lysinato(2-)]copper Monohydrochloride;AHK-Cu(2:1);ALA-HIS-LYS-CU(AHK-Cu);ACETYILHEXAPEPTIDE-8
CAS No.:682809-81-0
Molecular Formula:C15H24ClCuN6O4
InChIKeys:ZVDTZHLNTORZAU-FBSJPIKRNA-L
Molecular Weight:451.39
Categories:
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
tr
-
Location:
B27 SHING LEE COMM BLDG 8WING KUT ST CENTRAL HONGKONG
-
Average lead Time:
1
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History11 Inquiries
Country Product Purchase Quantity Date Posted
United States
AHK-Cu Directly Supply Bottom Price CAS 682809-81-0 Cosmetic Copper Peptide ghk-cu
1 MT Feb 5, 2026
United Kingdom
AHK-CU
5 G Aug 9, 2026
United States
AHK-Cu
10 PCS Jul 16, 2026
United States
Ahk-cu
20 MT Jun 14, 2026
United States
Ahk-cu
100 MT Apr 24, 2026
United States
AHK-cu
1 MT Mar 17, 2026
United States
AHK cu
1 KG Dec 15, 2025
United States
Ahk-cu
1 MT Nov 8, 2025
United States
AHK-CU
20 G Jun 29, 2026
United States
AHK-Cu
1 KG Nov 6, 2025
Sweden
GHK-Cu
1 KG Mar 17, 2026 Post an enquiry for this product